Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

valuation thoughts, page-165

First 165 Last

Share
Profile

Follow
arkus

939 Posts.

239

21/01/22

11:07

Post #: 59035275
Share

Originally posted by manlymanly: ↑

I was thinking the same.. I have Celularity in my google email alerts as I have two small parcels at $7 and $5 to get a bit of amniotic/Placental stem cell therapy exposure. Personally I think CHM has alot more to offer hence why my money is here and will continue to direct money here to buy more lower, wasn't the plan but 24.5 cents is an absolute bargain. Speaking of Celularity, Juno therapeutics sold to Celgene for $8b, Celularity is a spinoff from Cellgene. Cellgene was then sold to Bristol Myers Sqibb for $74b. There are some lofty buyouts in this space and CHM are building an impressive pipeline and the first cab of the rank in CHM-1101 is showing some real promise. A Fast track designation could come at anytime. Especially as the results of Cohort 2 would be collated and wrapped up so plenty to show the FDA. Jenn Chow said they are in close discussions with FDA in both the presentations late last year.

Expand

Be great to know who is offloading. Are there any professional investors here with access to broker data?

Would be good to see that last few months and in a few weeks time the data for this month.

Possible insider option conversion? Or those who IPO'ed sick and tired of waiting / looking to put money elsewhere.

CHM Price at posting: 24.3¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 216 more messages in this thread...

First 165 Last

Add CHM (ASX) to my watchlist